【手続補正書】
【提出日】平成16年10月15日(2004.10.15)
【手続補正１】
【補正対象書類名】明細書
【補正対象項目名】００４０
【補正方法】変更
【補正の内容】
【００４０】
【配列表】
SEQUENCE LISTING
<110> Japan Science And Technology Corporation
Sakamoto, Aiji
<120> A Method for Evalution or Identification for Bioactive Molecules
with the Use of Marker Genes.
<130> PC909155
<150> JP 2001-327576
<151> 2001-10-25
<160> 32
<170> PatentIn Ver. 2.1
<210> 1
<211> 900
<212> DNA
<213> Hamster sp.
<220>
<221> CDS
<222> (875)..(901)
<400> 1
tagcgctacc ggactcagat ctcgaggaag ctgtgtgacc ttggaggagg cactcccacc 60
tccataaact aaagcactca cttggatgga tcaccagaga cctgtctggc tctgaggctc 120
ggtgacctca acacattgtc tgctggccca aggaaagcgg tgcctgagcc agagttccag 180
tgtctaaact ctggtcattc ttcttcctcc ttaactagga agctgcctcc tagctgctcc 240
aatccagctg ccataccagg gccatgcccg actctgccct gcccctcttt gctgtggtaa 300
ctaggcccct tcccacctca gtgagatgtg ggactcaggc cagtagagta gggaggattc 360
tggaaacaga gccaggctag tgctgggggc caggactcca aggggcagca tgccagggca 420
gggcagggct ctgtctgcct aaggtcatgg tggtcgttgt cagcttactc tgcagtgagc 480
tgtggaatgt aagagatatt ttctgttcgc tttgagccac cccacccctt ggaactcaga 540
ccctgaacat gccatgccac aacaatgacg accacttcca attgtttcct ggctgggggg 600
ggagggggag cactgtttgg acaagggaag ggggggagtc gagggggaaa tgcttttagt 660
gacaacagcc ctttctaaat ctggctaggg actgggtgca ggtgggggtg ggggcacctt 720
ctgccccata tatacaaccc ctgaggccag gtctgactct gagcagtctc ctgctgtttc 780
cttccttgct gccctcaggt aggagtggga gctggaggcc tcctctggga taaggggctc 840
cagattcagg aagagggatc caccggtcgc cacc atg gtg agc aag ggc gag gag 895
Met Val Ser Lys Gly Glu Glu
1               5
ctg ttc                                                           901
Leu Phe
<210> 2
<211> 9
<212> PRT
<213> Hamster sp.
<400> 2
Met Val Ser Lys Gly Glu Glu Leu Phe
1               5
<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
prepro-endothelin-1 (ppET-1) , forward primer
<400> 3
ccaaggagct ccagaaacag                                             20
<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
prepro-endothelin-1(ppET-1) , reverse primer
<400> 4
ttgacccaga tgatgtccag                                             20
<210> 5
<211> 24
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
ETA endothelin receptor (ETAR) , forward primer
<400> 5
tctgcgcgct aagtgttgac aggt                                        24
<210> 6
<211> 24
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
ETA endothelin receptor (ETAR) , reverse primer
<400> 6
tcatcaggct ttaggactgg taac                                        24
<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
ETB endothelin receptor (ETBR) , forward primer
<400> 7
tctctgtggt tctggctgtc                                            20
<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
ETB endothelin receptor (ETBR) , reverse primer
<400> 8
tgctgaggtg aaggggaagc                                            20
<210> 9
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
AT1 angiotensin receptor (AT1R) , forward primer
<400> 9
gctgaagact gtggccagtg                                            20
<210> 10
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
AT1 angiotensin receptor (AT1R) , reverse primer
<400> 10
atgcaggtga ctttggctac                                            20
<210> 11
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
α1C adrenergic receptor (α1cAR) , forward primer
<400> 11
tccacggtgc tgcccttctc 20
<210> 12
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
α1C adrenergic receptor (α1cAR) , reverse primer
<400> 12
ttgatctggc agatggtctc                                            20
<210> 13
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
gp130 (cardiotrophin-1 receptor) , forward primer
<400> 13
cagaatgtgt atggagtcac                                            20
<210> 14
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
gp130 (cardiotrophin-1 receptor) , reverse primer
<400> 14
acccagactt caatgttgac                                            20
<210> 15
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
transforming growth factor β (TGFβ) , forward primer
<400> 15
aactattgct tcagctccac                                            20
<210> 16
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
transforming growth factor β (TGFβ) , reverse primer
<400> 16
acgtagtaca cgatgggcag                                            20
<210> 17
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
protein kinase Cβ (PKCβ) , forward primer
<400> 17
gcagccactg caccgacttc                                            20
<210> 18
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
protein kinase Cβ (PKCβ) , reverse primer
<400> 18
acgtagggat ctgacaagcc                                            20
<210> 19
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
c-myc , forward primer
<400> 19
acagcaaacc tccgcacag                                             19
<210> 20
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
c-myc , reverse primer
<400> 20
tggtcacgca gggcaaaaa                                             19
<210> 21
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
c-fos , forward primer
<400> 21
gccccatcgc agaccagagc                                            20
<210> 22
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
c-fos , reverse primer
<400> 22
atgctgctga tgctcttgac                                            20
<210> 23
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
c-ras , forward primer
<400> 23
caccatagag gtgagctctg                                            20
<210> 24
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
c-ras , reverse primer
<400> 24
tcctcttggc ctgctgtgtc                                            20
<210> 25
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
β-MHC , forward primer
<400> 25
cgcatggacc tggagcgagc                                            20
<210> 26
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
β-MHC , reverse primer
<400> 26
cgccgcatct tccggaactc                                            20
<210> 27
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
GAPDH , forward primer
<400> 27
accacagtcc atgccatcac                                            20
<210> 28
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
GAPDH , reverse primer
<400> 28
tccaccaccc tgttgctgta                                            20
<210> 29
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
forward primer (F1)
<400> 29
cgctcgagga agctgtgtga ccttggag                                    28
<210> 30
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:
reverse primer (R2)
<400> 30
cgggatccct cttcctgaat ctggagcc                                    28
<210> 31
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:GFP-F
<400> 31
tcgccaccat ggtgagcaag                                             20
<210> 32
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Description of Artificial Sequence:GFP-R
<400> 32
cctagcagaa gcacaggctg                                             20